Layered double hydroxide nanoparticles for biomedical applications: Current status and recent prospects
Source abstract
Abstract
Abstract Layered double hydroxides (LDH), also known as hydrotalcite like compounds are well known for their peculiar characteristics like good biocompatibility, anion exchange capacity, high chemical stability and pH-dependent solubility which aid for the design of smart drug delivery systems. This review focuses on the most recent progress in the synthesis of LDH along with the current methods for controlling the structural properties and chemical functionalization for biotechnological and biomedical applications. The recent research on the pathways of particle entry into the cells is described. One of the promising areas of interest in nanotechnology is the development of targeted drug delivery systems with controlled release properties; the contribution of LDH towards these topics is also summarized. In addition, we highlighted the significant achievements made in the delivery of genes and imageable agents using LDH. Further we briefly conferred the latest breakthroughs in the fabrication of hybrid LDH for obtaining novel properties followed by the applications of LDH in various fields of biomedicine. We critically discuss burning questions especially related to the toxicological evaluation of LDH nanoparticles in order to enable a fast transition to clinical trials of this promising drug delivery platform.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Magnesium Oxide Properties and Applications · Inorganic Chemistry and Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Bionanocomposites based on alginate-zein/layered double hydroxide materials as drug delivery systems10.1039/c0jm01211d ↗
2. Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells10.2147/IJN.S30809 ↗
3. Nanostructured materials for advanced energy conversion and storage devices10.1038/nmat1368 ↗
4. Bioinorganic magnetic core-shell nanocomposites carrying antiarthritic agents: intercalation of ibuprofen and glucuronic acid into Mg-Al-layered double hydroxides supported on magnesium ferrite10.1021/ic901097a ↗
5. Prolate spheroidal hematite particles equatorially belt with drug-carrying layered double hydroxide disks: Ring Nebula-like nanocomposites10.1186/1556-276X-6-116 ↗
6. Synthesis of well-dispersed layered double hydroxide core@ordered mesoporous silica shell nanostructure (LDH@mSiO2) and its application in drug delivery10.1039/c1nr10718f ↗
7. Preparation and controlled-release studies of a protocatechuic acid-magnesium/aluminum-layered double hydroxide nanocomposite10.2147/IJN.S42718 ↗
8. Drug delivery system for an anticancer agent, chlorogenate-Zn/Al-layered double hydroxide nanohybrid synthesised using direct co-precipitation and ion exchange methods10.1016/j.jssc.2014.04.015 ↗
9. Synthesis of protocatechuic acid-zinc/aluminium-layered double hydroxide nanocomposite as an anticancer nanodelivery system10.1016/j.jssc.2014.09.001 ↗
10. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure10.1016/j.berh.2012.07.008 ↗
11. Layered Double Hydroxide-Based Nanocarriers for Drug Delivery10.3390/pharmaceutics6020298 ↗
12. Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma10.1002/cmmi.494 ↗
13. Layered double hydroxides reconstructed in calcium glutamate aqueous solution as a complex delivery system10.1016/j.clay.2012.04.031 ↗
14. The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics10.1007/s10856-012-4638-y ↗
15. Silver Nanoparticles Deposited Layered Double Hydroxide Nanoporous Coatings with Excellent Antimicrobial Activities10.1002/adfm.201102333 ↗
16. Nanomaterials for renewable energy production and storage10.1039/c2cs35230c ↗
17. A facile synthesis of strong near infrared fluorescent layered double hydroxide nanovehicles with an anticancer drug for tumor optical imaging and therapy10.1039/c3nr00781b ↗
18. Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of siRNA delivery10.1016/j.jcis.2012.09.033 ↗
19. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity10.2217/nnm.11.86 ↗
20. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance10.1039/b925831k ↗
21. Drug-Ceramic 2-Dimensional Nanoassemblies for Drug Delivery System in Physiological Condition10.1111/j.1551-2916.2012.05219.x ↗
22. Intercalative Nanohybrids of Nucleoside Monophosphates and DNA in Layered Metal Hydroxide10.1021/ja981823f ↗
23. Inorganic Layered Double Hydroxides as Nonviral Vectors10.1002/1521-3773(20001117)39:22<4041::AID-ANIE4041>3.0.CO;2-C ↗
24. Layered double hydroxide as an efficient drug reservoir for folate derivatives10.1016/j.biomaterials.2003.09.083 ↗
25. Inorganic-Biomolecular Hybrid Nanomaterials as a Genetic Molecular Code System10.1002/adma.200400027 ↗
26. Clay minerals and layered double hydroxides for novel biological applications10.1016/j.clay.2006.07.007 ↗
27. Gene and Drug Delivery System with Soluble Inorganic Carriers
28. Intracellular trafficking pathway of layered double hydroxide nanoparticles in human cells: Size-dependent cellular delivery10.1016/j.clay.2012.06.007 ↗
29. Modified hydrotalcite-like compounds as active fillers of biodegradable polymers for drug release and food packaging applications10.2174/187221012803531493 ↗
30. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
31. Layered double hydroxides and human health: An overview10.1016/j.clay.2006.06.010 ↗
32. Polymer nanocomposites for improved drug delivery efficiency10.1016/j.matchemphys.2011.11.046 ↗
33. Performance-enhanced cholesterol biosensor based on biocomposite system: Layered double hydroxides-chitosan10.1016/j.jelechem.2011.04.003 ↗
34. Intercalation and controlled release properties of vitamin C intercalated layered double hydroxide10.1016/j.jssc.2013.04.028 ↗
35. Nanoparticles as smart treatment-delivery systems in plants: Assessment of different techniques of microscopy for their visualization in plant tissues10.1093/aob/mcm283 ↗
36. Cellular trafficking of low molecular weight heparin incorporated in layered double hydroxide nanoparticles in rat vascular smooth muscle cells10.1016/j.biomaterials.2011.05.083 ↗
37. Antibody-targeted drug delivery to injured arteries using layered double hydroxide nanoparticles10.1002/adhm.201200069 ↗
38. Size control and optimisation of intercalated layered double hydroxides
39. Layered double hydroxides as efficient drug delivery system of ciprofloxacin in the middle ear: an animal study in rabbits10.1007/s10856-012-4769-1 ↗
40. Preparation and evaluation of well-defined hemocompatible layered double hydroxide-poly(sulfobetaine) nanohybrids10.1039/c2jm32720a ↗
41. Functionalized Layered Double Hydroxide Nanoparticles Conjugated with Disulfide-Linked Polycation Brushes for Advanced Gene Delivery10.1021/bc300683y ↗
42. Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme10.2147/IJN.S32267 ↗
43. Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite10.2147/IJN.S30461 ↗
44. Synthesis of a Layered Organic-Inorganic Nanohybrid of 4-Chlorophenoxyacetate-zinc-Layered Hydroxide with Sustained Release Properties10.1155/2012/860352 ↗
45. Bone cement/layered double hydroxide nanocomposites as potential biomaterials for joint implant10.1002/jbm.a.34296 ↗
46. Katz · 2005 · 368
47. Applications of nanomaterials in agricultural production and crop protection: A review10.1016/j.cropro.2012.01.007 ↗
48. Gadolinium (III) diethylenetriamine pentaacetic acid/ layered double hydroxide nanohybrid as novel T1-magnetic resonant nanoparticles10.1166/jnn.2008.1337 ↗
49. Drug-inorganic-polymer nanohybrid for transdermal delivery10.1016/j.ijpharm.2012.12.043 ↗
50. Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment
51. Intercalation of paracetamol into the hydrotalcite-like host10.1016/j.jssc.2011.10.029 ↗
52. Layered double hydroxide nanoparticles to enhance organ-specific targeting and the anti-proliferative effect of cisplatin10.1039/C4TB01989J ↗
53. Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent10.2147/IJN.S39740 ↗
54. Functionalization of mesoporous silica nanoparticles for targeting, biocompatibility, combined cancer therapies and theragnosis10.1166/jnn.2013.7363 ↗
55. Layered double hydroxide nanoparticles in gene and drug delivery10.1517/17425240903130585 ↗
56. Controlled preparation of layered double hydroxide nanoparticles and their application as gene delivery vehicles10.1016/j.clay.2009.11.032 ↗
57. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles10.1016/j.biomaterials.2009.10.058 ↗
58. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles10.1016/j.biomaterials.2013.06.046 ↗
59. Cellular uptake and gene delivery using layered double hydroxide nanoparticles10.1039/C2TB00081D ↗
60. Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles10.1016/j.biomaterials.2013.12.095 ↗
61. Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics10.1039/C4CC03118K ↗
62. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery10.1021/nn800072t ↗
63. Synthesis of nanorattles with layered double hydroxide core and mesoporous silica shell as delivery vehicles10.1039/c1jm12054a ↗
64. Gene delivery by functional inorganic nanocarriers10.2174/187221512801327361 ↗
65. Frontier of therapeutic antibody discovery: The challenges and how to face them10.4331/wjbc.v3.i12.187 ↗
66. Novel Pt-loaded layered double hydroxide nanoparticles for efficient and cancer-cell specific delivery of a cisplatin prodrug10.1039/C4TB00645C ↗
67. Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes10.2967/jnumed.106.039131 ↗
68. Electrospun fibers of layered double hydroxide/biopolymer nanocomposites as effective drug delivery systems10.1016/j.matchemphys.2012.03.041 ↗
69. Target delivery and controlled release of the chemopreventive drug sulindac by using an advanced layered double hydroxide nanomatrix formulation system10.1007/s10856-012-4566-x ↗
70. Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery10.1016/j.addr.2012.12.003 ↗
71. Layered double hydroxide nanoparticles incorporating terbium: applicability as a fluorescent probe and morphology modifier10.1007/s11051-008-9583-9 ↗
72. Encapsulation of nucleotides and DNA into Mg-Al layered double hydroxide10.1016/j.ijpharm.2010.04.013 ↗
73. Synthesis and Characterization of Ifosfamide Intercalated Layered Double Hydroxides10.1080/01932691.2011.562446 ↗
74. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: Enhanced efficacy due to clathrin-mediated endocytosis10.1021/bc0601323 ↗
75. Intracrystalline structure of DNA molecules stabilized in the layered double hydroxide10.1016/j.jpcs.2006.01.080 ↗
76. Inorganic Metal Hydroxide Nanoparticles for Targeted Cellular Uptake Through Clathrin-Mediated Endocytosis10.1002/asia.200800290 ↗
77. Nearly monodispersed core-shell structural Fe3O4@DFUR-LDH submicro particles for magnetically controlled drug delivery and release10.1039/C0CC01313G ↗
78. Antibody-labeled gold nanoconjugates in experimental physiology and cancer research
79. The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids10.2147/IJN.S43203 ↗
80. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications10.1007/s00330-002-1721-7 ↗
81. Pectin-coated chitosan-LDH bionanocomposite beads as potential systems for colon-targeted drug delivery10.1016/j.ijpharm.2013.12.035 ↗
82. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds10.1016/j.phrs.2010.01.009 ↗
83. Layered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): a review10.1016/j.jconrel.2013.03.034 ↗
84. Intercalation of drugs in layered double hydroxides and their controlled release: A review10.1016/j.clay.2013.12.002 ↗
85. Modeling drug release from a layered double hydroxide-ibuprofen complex10.1016/j.clay.2012.04.004 ↗
86. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage10.2217/nnm.11.166 ↗
87. Studies on the stability and kinetics of drug release of dexamethasone phosphate intercalated layered double hydroxides nanohybrids10.1016/j.matchemphys.2013.07.001 ↗
88. Antituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocomposites
89. Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites10.1016/j.clay.2012.10.014 ↗
90. Charge density and particle size effects on oligonucleotide and plasmid DNA binding to nanosized hydrotalcite10.1186/1559-4106-8-8 ↗
91. Preparation of Fe3O4@SiO2@layered double hydroxide core-shell microspheres for magnetic separation of proteins10.1021/ja2086323 ↗
92. Layered double hydroxides as carriers for quantum dots@silica nanospheres10.1039/c2nr31550e ↗
93. Nanotechnology-based flexible electronics10.1088/0957-4484/23/34/340201 ↗
94. Effect of layered double hydroxide intercalated with fluoride ions on the physical, biological and release properties of a dental composite resin10.1016/j.jdent.2013.10.019 ↗
95. Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells10.1039/b905158a ↗
96. Intercalation, delivery, and expression of the gene encoding green fluorescence protein utilizing nanobiohybrids10.1016/j.jconrel.2004.07.035 ↗
97. Synthesis, characterization, and controlled release antibacterial behavior of antibiotic intercalated Mg-Al layered double hydroxides10.1016/j.materresbull.2012.08.029 ↗
98. Controlled drug release characteristics and enhanced antibacterial effect of graphene oxide-drug intercalated layered double hydroxide hybrid films10.1039/c2jm35144g ↗
99. A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery10.1016/j.biomaterials.2013.01.070 ↗
100. Synthesis of chitosan-coated near-infrared layered double hydroxide nanoparticles for in vivo optical imaging10.1039/c2jm16447g ↗